BRPI0414157A - polipeptìdeo isolado, ácido nucleico isolado, método para inibir a infecção por vìrus da sìndrome da mancha branca de um crustáceo, e, alimento para um crustáceo - Google Patents

polipeptìdeo isolado, ácido nucleico isolado, método para inibir a infecção por vìrus da sìndrome da mancha branca de um crustáceo, e, alimento para um crustáceo

Info

Publication number
BRPI0414157A
BRPI0414157A BRPI0414157A BRPI0414157A BR PI0414157 A BRPI0414157 A BR PI0414157A BR PI0414157 A BRPI0414157 A BR PI0414157A BR PI0414157 A BRPI0414157 A BR PI0414157A
Authority
BR
Brazil
Prior art keywords
crustacean
white spot
syndrome virus
spot syndrome
food
Prior art date
Application number
Other languages
English (en)
Inventor
Kurt R Klimpel
Original Assignee
Aquabounty Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aquabounty Technologies Inc filed Critical Aquabounty Technologies Inc
Publication of BRPI0414157A publication Critical patent/BRPI0414157A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/23—Immunoglobulins specific features characterized by taxonomic origin from birds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/18011—Nimaviridae
    • C12N2710/18022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/18011—Nimaviridae
    • C12N2710/18034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

"POLIPEPTìDEO ISOLADO, áCIDO NUCLEICO ISOLADO, MéTODO PARA INIBIR A INFECçãO POR VìRUS DA SìNDROME DA MANCHA BRANCA DE UM CRUSTáCEO, E, ALIMENTO PARA UM CRUSTáCEO". A presente invenção refere-se a uma composição nova útil para inibir a infecção por Vírus da Sindrome da Mancha Branca (WSSV) de animais crustáceos, particularmente daqueles do gênero Penaeus sp. Mais especificamente, a composição nova compreende um polipeptídeo cuja seqüência de aminoácidos corresponde a pelo menos uma porção de Vp28, uma proteína de superfície de WSSV, ou wn anticorpo que especificamente se liga no polipeptídeo. As seqüências de polinucleotídeo codificadoras dos polipeptídeos Vp28 da presente invenção também são descritas. São adicionalmente descritos métodos para usar as composições novas para inibir a infecção por WSSV em animais crustáceos.
BRPI0414157 2003-09-09 2004-09-09 polipeptìdeo isolado, ácido nucleico isolado, método para inibir a infecção por vìrus da sìndrome da mancha branca de um crustáceo, e, alimento para um crustáceo BRPI0414157A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50161403P 2003-09-09 2003-09-09
PCT/US2004/029438 WO2005023992A2 (en) 2003-09-09 2004-09-09 Compositions and methods for inhibiting white spot syndrome virus (wssv) infection

Publications (1)

Publication Number Publication Date
BRPI0414157A true BRPI0414157A (pt) 2006-10-31

Family

ID=34273061

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0414157 BRPI0414157A (pt) 2003-09-09 2004-09-09 polipeptìdeo isolado, ácido nucleico isolado, método para inibir a infecção por vìrus da sìndrome da mancha branca de um crustáceo, e, alimento para um crustáceo

Country Status (10)

Country Link
US (1) US20070059808A1 (pt)
EP (1) EP1664268A4 (pt)
CN (1) CN101166752A (pt)
AU (1) AU2004271211A1 (pt)
BR (1) BRPI0414157A (pt)
CA (1) CA2537995A1 (pt)
EC (1) ECSP066495A (pt)
MX (1) MXPA06002730A (pt)
WO (1) WO2005023992A2 (pt)
ZA (1) ZA200602871B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070148166A1 (en) * 2002-05-13 2007-06-28 Wu Madeline C S Scfvs in photosynthetic microbes
BRPI0913246A2 (pt) * 2008-06-20 2016-01-19 Univ Wageningen molécula de ácido nucleico de vírus da síndrome da mancha branca, proteína de vírus da síndrome da mancha branca, composição farmacêutica, uso de uma proteína de vírus da síndrome da mancha branca ou um fragmento da mesma, vacina para combater infecção por vírus da síndrome da mancha branca, teste diagnóstico para a detecção de dna específico de vírus da síndrome da mancha branca, e, anticorpos
CN101691403B (zh) * 2009-08-03 2011-11-09 中国海洋大学 抗对虾白斑症病毒囊膜蛋白vp28独特型单克隆抗体及其制备方法
CN101919873B (zh) * 2010-07-16 2011-05-04 韩健宝 抗wssv和/或tsv的核酸药物
US20120107355A1 (en) 2010-10-27 2012-05-03 Harrisvaccines, Inc. Method of rapidly producing improved vaccines for animals
US8822427B2 (en) 2010-10-27 2014-09-02 Harrisvaccines Methods and compositions to protect aquatic invertebrates from disease
US10004797B2 (en) 2010-10-27 2018-06-26 Harrisvaccines, Inc. Method of rapidly producing improved vaccines for animals
MY153741A (en) 2010-11-10 2015-03-13 Univ Malaya A method for producing bio-active agent for the prevention of disease caused by white spot syndrome baculovirus complex and a bio-active agent derived thereof
MY161995A (en) * 2010-11-10 2017-05-31 Univ Malaya Vaccine against white spot syndrome virus
CN103766626B (zh) * 2012-10-22 2015-05-06 中国科学院海洋研究所 一种预防对虾白斑病的饲料添加剂及其制备方法
CN107881258A (zh) * 2017-11-14 2018-04-06 上海海洋大学 Vp53b基因及蛋白在制备防治对虾白斑综合征的药物中的应用
CN109517037B (zh) * 2018-10-31 2022-02-08 青岛科技大学 具有白斑综合征病毒抑制作用的多肽及其应用
CN109673869A (zh) * 2018-12-27 2019-04-26 南京瑞碧斯生物科技有限公司 一种修复免疫抗应激能力的虾蟹饵料及其应用
KR102330545B1 (ko) * 2019-11-18 2021-11-29 (주)애드바이오텍 새우 폐사 방지용 난황항체의 제조방법
CN112094853A (zh) * 2020-09-24 2020-12-18 扬州大学 白斑综合征病毒vp28基因、重组蛋白、多克隆抗体及制备方法和应用
CN114875035B (zh) * 2022-04-25 2024-11-22 闽江学院 一种凡纳滨对虾溶质转运基因LvSLC5A8及其编码蛋白和应用
CN118530375B (zh) * 2024-07-26 2024-11-05 山东省动物疫病预防与控制中心(山东省人畜共患病流调监测中心) 一种白斑综合征病毒的多表位融合蛋白、抗体、编码基因和重组质粒以及它们的用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60024100D1 (de) * 1999-08-03 2005-12-22 Akzo Nobel Nv Von dem syndrom der weissen flecken virus abgeleitete proteine und deren verwendungen
CN1303942A (zh) * 1999-11-24 2001-07-18 国家海洋局第三海洋研究所 对虾白斑杆状病毒基因组DNA序列及c DNA序列
US7410637B2 (en) * 2000-06-20 2008-08-12 Phycotransgenics, Llc Transgenic algae for delivering antigens to an animal
WO2003000900A1 (en) * 2001-06-22 2003-01-03 Akzo Nobel N.V. White spot syndrome virus vaccine

Also Published As

Publication number Publication date
EP1664268A4 (en) 2008-09-03
AU2004271211A1 (en) 2005-03-17
CA2537995A1 (en) 2005-03-17
MXPA06002730A (es) 2006-09-04
ZA200602871B (en) 2008-07-30
CN101166752A (zh) 2008-04-23
EP1664268A2 (en) 2006-06-07
WO2005023992A3 (en) 2007-07-05
US20070059808A1 (en) 2007-03-15
ECSP066495A (es) 2006-11-24
WO2005023992A2 (en) 2005-03-17

Similar Documents

Publication Publication Date Title
BRPI0414157A (pt) polipeptìdeo isolado, ácido nucleico isolado, método para inibir a infecção por vìrus da sìndrome da mancha branca de um crustáceo, e, alimento para um crustáceo
ES2505695T3 (es) Composiciones inmunógenas para Streptococcus pyogenes
BR0012919A (pt) Vacina para uso na profilaxia e/ou no tratamento da sìndrome de ponto branco (white spot syndrome) em crustáceos, proteìna estrutural derivada do vìrus da sìndrome de ponto branco, sequência de ácido nucléico, uso de uma proteìna estrutural, composição farmacêutica, anticorpos, vacina ou formulação farmacêutica, e, kit diagnóstico para detecção de wssv
CY1110862T1 (el) Πεπτιδια που προκαλουν ανοσολογικη ανοχη απο βασικη πρωτεϊνη της μυελινης
EA200901129A1 (ru) Нуклеиновые кислоты и полипептиды нового рецептора
ATE352559T1 (de) Verfahren zur verminderung der immunogenität von proteinen
PT1090033E (pt) Particulas de proteinas de envelope do hcv: utilizacao para vacinacao
MXPA02011545A (es) Virus del sindrome respiratorio y reproductor porcino (peesv), vacuna recombinante para el virus de la viruela.
BRPI0414810A (pt) composições baseadas no vìrus seneca valley e métodos para tratar doença
AR008588A1 (es) Molecula de acido nucleico aislada que hibridiza con un gen de saliva de pulga, proteina aislada codificada por dicha molecula, composicion terapeuticapara tratar la dermatitis alergica, kit de ensayo para determinar dicha dermatitis, molecula, virus y celula recombinantes, y anticuerpo aislado
DE60233532D1 (de) An proteinphosphatase 2a bindende synthetische ode anwendungen
DE602004027362D1 (de) Zusammensetzungen und verfahren mit dem respiratory syncytial virus untergruppe b stamm 9320
DK1276763T3 (da) Anti-fryseproteiner, deres fremstilling og anvendelse
CY1109244T1 (el) Νευρολοιμογονο στελεχος του ιου δυτικου νειλου και εφαρμογες αυτου.
BR0016129A (pt) Molécula de ácido nucléico, vetor recombinante, polipeptìdeo, racemase de aminoácido eucariótica, anticorpos, célula hospedeira, métodos para produzir polipeptìdeo, para detectar um parasita e uma proteìna eucariótica, para triar moléculas ativas, para detectar e quantificar a presença ou a ausência de uma sequência, para inibir uma proteìna eucariótica, para produzir uma racemase de aminoácido recombinante eucariótica e d-aminoácio e para prevenir ou inibir infecção, plasmìdeo, complexo imunológico, kit para detectar um parasita, fragmento de um polinucleotìdeo, proteìna eucariótica, processos para preparar uma proteìna eucariótica purificada, para detectar uma infecção e para infecção e para triar uma molécula, composição imunizadora, composição de vacina, qualquer modificação molecular do gene ou de um fragmento do gene, uso de qualquer modificação molecular ou bioquìmica da atividade enzimática da racemase, e, qualquer molécula ou composto
FI972170A0 (fi) Peptidejä, jotka kykenevät sitoutumaan GAP-proteiinin SH3-domeeniin, näitä peptidejä koodittavia nukleotidisekvenssejä, niiden valmistus ja käyttö
DK1219301T3 (da) Vacciner, som indeholder hybridpolypeptider, der består af mindst to forskellige allergene proteiner
ATE543513T1 (de) Anti-coronavirus impfstoff
DK1075523T3 (da) Strukturelle proteiner hos fiskepankreassygdomsvirus og anvendelser deraf
EA200200743A1 (ru) Рекомбинантное ослабление вируса репродуктивного и респираторного синдрома свиней (prrsv)
NO20060675L (no) Forbedrede, rekombinante, humane interferon-beta-lb-polypeptider
WO2023031306A3 (en) New coronavirus vaccine and method for designing and obtaining a virus vaccine
WO2004082596A3 (en) Yersinia species compositions
DK0811068T3 (da) Humane DNase I varianter
EA202092934A1 (ru) Композиции и способы для посттрансляционной модификации in vivo

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.